Fragment-based discovery and optimization of BACE1 inhibitors.
Madden, J., Dod, J.R., Godemann, R., Kraemer, J., Smith, M., Biniszkiewicz, M., Hallett, D.J., Barker, J., Dyekjaer, J.D., Hesterkamp, T.(2010) Bioorg Med Chem Lett 20: 5329-5333
- PubMed: 20656487 Search on PubMed
- DOI: https://doi.org/10.1016/j.bmcl.2010.06.089
- Primary Citation Related Structures: 
3MSJ, 3MSK, 3MSL, 3S2O - PubMed Abstract: 
A novel series of 2-aminobenzimidazole inhibitors of BACE1 has been discovered using fragment-based drug discovery (FBDD) techniques. The rapid optimization of these inhibitors using structure-guided medicinal chemistry is discussed.
- Evotec UK Ltd, Abingdon, UK. james.madden@evotec.com
Organizational Affiliation: 
















